
Andrew Hahn
Articles
-
Nov 25, 2024 |
mx.advfn.com | Andrew Hahn |Managing Member
SEC Form 4 FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIPFiled pursuant to Section 16(a) of the Securities Exchange Act of 1934or Section 30(h) of the Investment Company Act of 1940OMB APPROVALOMB Number:3235-0287Estimated average burdenhours per response:0.5Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
-
Oct 9, 2024 |
digitalcommons.library.tmc.edu | Andrew Johns |Matthew Campbell |Mamie Gao |Andrew Hahn
BACKGROUND: Tivozanib has been approved as a third-line or later therapy for advanced renal cell carcinoma based on the TIVO-3 trial, which was conducted before immune checkpoint therapies (ICT), cabozantinib, and lenvatinib/everolimus became incorporated in the current sequential treatment paradigm for advanced clear cell RCC (ccRCC). METHODS: We performed a retrospective study of patients with advanced ccRCC treated with tivozanib at MD Anderson Cancer Center during 6/2021-7/2023.
-
Aug 23, 2024 |
digitalcommons.library.tmc.edu | Andrew Hahn |Bilal Siddiqui |Javier Leo |Eleonora Dondossola
AbstractGiven the central role of the androgen receptor (AR) in prostate cancer cell biology, AR-targeted therapies have been the backbone of prostate cancer treatment for over 50 years. New data indicate that AR is expressed in additional cell types within the tumor microenvironment. Moreover, targeting AR for the treatment of prostate cancer has established side effects such as bone complications and an increased risk of developing cardiometabolic disease, indicating broader roles for AR.
-
Jul 30, 2024 |
theadroitjournal.org | Andrew Hahn
Back to Issue FiftyBY ANDREW HAHNChristian Gullette’s debut poetry collection Coachella Elegy won the Trio House Press Trio Award. His poems have appeared in The New Republic, The American Poetry Review, Kenyon Review, Poem-a-Day (Academy of American Poets), and The Yale Review. He has received financial support from the Bread Loaf Writers’ Conference and the Kenyon Review Writers Workshops.
-
Jul 16, 2024 |
nature.com | Andrew Hahn |Rebecca S. Tidwell |Amado J. Zurita |Sumit K. Subudhi |Pavlos Msaouel |Efstratios Koutroumpakis | +2 more
AbstractAndrogen signaling is central to prostate cancer and men’s health. Prior data indicates that increasing body fat is unfavorable in the localized setting yet associated with favorable outcomes in men with metastatic disease. Understanding the biological links between adiposity and prostate cancer may optimize the therapeutic index with ASI.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →